Moderna Announces Presentation of Interim Data from Phase 1 Study of mRNA Triplet Program at 2021 SITC Annual Meeting
Go back to Moderna Announces Presentation of Interim Data from Phase 1 Study of mRNA Triplet Program at 2021 SITC Annual Meeting| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 167.45 +13.41 (8.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $154.04 | 52 Week High | $0.52 | |||
| Open | $161.05 | 52 Week Low | $0.08 | |||
| Day High | $170.15 | P/E | N/A | |||
| Day Low | $159.06 | EPS | $-3.80 | |||
| Volume | 9,451,471 | |||||
